Filing Flows › Comparisons › XLO vs RMTI
Xilio Therapeutics vs Rockwell Medical: XLO and RMTI compared
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $17.8M for Rockwell Medical (Q2 2026). Xilio Therapeutics is growing faster (+131% against +11% a year earlier). Rockwell Medical is more profitable, with an operating margin of -6.0% against -18.7%.
Where the money goes: XLO and RMTI
Xilio Therapeutics (XLO) · Q2 2026
Xilio Therapeutics, Q2 2026: revenue $18.7M (+131% year over year), operating margin -18.7%, net loss $6.4M, operating cash flow −$18.8M. The chart follows the revenue to costs, profit and cash.
Rockwell Medical (RMTI) · Q2 2026
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
| Xilio Therapeutics (XLO) | Rockwell Medical (RMTI) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $18.7M | $17.8M |
| Revenue growth, Y/Y | +131% | +11% |
| Operating margin | -18.7% | -6.0% |
| Net earnings | −$6.4M | −$1.2M |
| Net margin | -34.1% | -6.6% |
| Operating cash flow | −$18.8M | $2.1M |
| Free cash flow | — | $1.5M |
Questions
Which is bigger, Xilio Therapeutics or Rockwell Medical?
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $17.8M for Rockwell Medical (Q2 2026).
Is Xilio Therapeutics or Rockwell Medical growing faster?
Xilio Therapeutics is growing faster (+131% against +11% a year earlier).
Which is more profitable, Xilio Therapeutics or Rockwell Medical?
Rockwell Medical is more profitable, with an operating margin of -6.0% against -18.7%.
More: Xilio Therapeutics earnings · how Xilio Therapeutics makes money · Rockwell Medical earnings · how Rockwell Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.